Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjung Song

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Leukemia Research|July 10, 2012
Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cellsJung-Hyun Kim, Minjung Song, Geun-Ho Kang, et al.
Nature Communications|January 5, 2012
Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria modelMitra Lavasani, Andria R Robinson, Aiping Lu, et al.
Plos One|June 13, 2014
Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiolHye Yeon Choi, Seung Woo Kim, BongWoo Kim, et al.
Genome Research|January 13, 2018
Targeting mutant <i>KRAS</i> with CRISPR-Cas9 controls tumor growthWonjoo Kim, Sangeun Lee, Han Sang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive TumorsSophie Archer, Phillip M Brailey, Minjung Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2025
A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumorsJohann S de Bono, Anja Williams, Ignacio Melero, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Leukemia Research|July 10, 2012
Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cellsJung-Hyun Kim, Minjung Song, Geun-Ho Kang, et al.
Nature Communications|January 5, 2012
Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria modelMitra Lavasani, Andria R Robinson, Aiping Lu, et al.
Plos One|June 13, 2014
Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiolHye Yeon Choi, Seung Woo Kim, BongWoo Kim, et al.
Genome Research|January 13, 2018
Targeting mutant <i>KRAS</i> with CRISPR-Cas9 controls tumor growthWonjoo Kim, Sangeun Lee, Han Sang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive TumorsSophie Archer, Phillip M Brailey, Minjung Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2025
A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumorsJohann S de Bono, Anja Williams, Ignacio Melero, et al.
Pageof 4